» Articles » PMID: 19264960

Interprotofilament Interactions Between Alzheimer's Abeta1-42 Peptides in Amyloid Fibrils Revealed by CryoEM

Overview
Specialty Science
Date 2009 Mar 7
PMID 19264960
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease is a neurodegenerative disorder characterized by the accumulation of amyloid plaques in the brain. This amyloid primarily contains amyloid-beta (Abeta), a 39- to 43-aa peptide derived from the proteolytic cleavage of the endogenous amyloid precursor protein. The 42-residue-length Abeta peptide (Abeta(1-42)), the most abundant Abeta peptide found in plaques, has a much greater propensity to self-aggregate into fibrils than the other peptides and is believed to be more pathogenic. Synthetic human Abeta(1-42) peptides self-aggregate into stable but poorly-ordered helical filaments. We determined their structure to approximately 10-A resolution by using cryoEM and the iterative real-space reconstruction method. This structure reveals 2 protofilaments winding around a hollow core. Previous hairpin-like NMR models for Abeta(17-42) fit well in the cryoEM density map and reveal that the juxtaposed protofilaments are joined via the N terminus of the peptide from 1 protofilament connecting to the loop region of the peptide in the opposite protofilament. This model of mature Abeta(1-42) fibrils is markedly different from previous cryoEM models of Abeta(1-40) fibrils. In our model, the C terminus of Abeta forms the inside wall of the hollow core, which is supported by partial proteolysis analysis.

Citing Articles

Principles and Biomedical Applications of Self-Assembled Peptides: Potential Treatment of Type 2 Diabetes Mellitus.

Mohammad Karim A Pharmaceutics. 2024; 16(11).

PMID: 39598565 PMC: 11597675. DOI: 10.3390/pharmaceutics16111442.


Interaction of Proteins Involved in Neuronal Proteinopathies.

Kulichikhin K, Malikova O, Zobnina A, Zalutskaya N, Rubel A Life (Basel). 2023; 13(10).

PMID: 37895336 PMC: 10608209. DOI: 10.3390/life13101954.


Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer's disease.

Pradhan A, Neumuller T, Klug C, Fuchs S, Schlegel M, Ballmann M Transl Psychiatry. 2023; 13(1):332.

PMID: 37891168 PMC: 10611770. DOI: 10.1038/s41398-023-02630-z.


Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids.

Scheres S, Ryskeldi-Falcon B, Goedert M Nature. 2023; 621(7980):701-710.

PMID: 37758888 DOI: 10.1038/s41586-023-06437-2.


Big versus small: The impact of aggregate size in disease.

Hnath B, Chen J, Reynolds J, Choi E, Wang J, Zhang D Protein Sci. 2023; 32(7):e4686.

PMID: 37243896 PMC: 10273386. DOI: 10.1002/pro.4686.


References
1.
Serpell L, Smith J . Direct visualisation of the beta-sheet structure of synthetic Alzheimer's amyloid. J Mol Biol. 2000; 299(1):225-31. DOI: 10.1006/jmbi.2000.3650. View

2.
Serpell L, Sunde M, Benson M, Tennent G, Pepys M, Fraser P . The protofilament substructure of amyloid fibrils. J Mol Biol. 2000; 300(5):1033-9. DOI: 10.1006/jmbi.2000.3908. View

3.
Goldsbury C, Wirtz S, Muller S, Sunderji S, Wicki P, Aebi U . Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors. J Struct Biol. 2000; 130(2-3):217-31. DOI: 10.1006/jsbi.2000.4259. View

4.
Egelman E . A robust algorithm for the reconstruction of helical filaments using single-particle methods. Ultramicroscopy. 2000; 85(4):225-34. DOI: 10.1016/s0304-3991(00)00062-0. View

5.
Kowalewski T, Holtzman D . In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc Natl Acad Sci U S A. 1999; 96(7):3688-93. PMC: 22355. DOI: 10.1073/pnas.96.7.3688. View